1. Home
  2. AAOI vs APLS Comparison

AAOI vs APLS Comparison

Compare AAOI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Optoelectronics Inc.

AAOI

Applied Optoelectronics Inc.

N/A

Current Price

$106.28

Market Cap

3.0B

Sector

Technology

ML Signal

N/A

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

N/A

Current Price

$18.39

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAOI
APLS
Founded
1997
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
AAOI
APLS
Price
$106.28
$18.39
Analyst Decision
Buy
Buy
Analyst Count
6
20
Target Price
$66.80
$31.89
AVG Volume (30 Days)
7.4M
1.7M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
85.78
112.50
EPS
N/A
0.20
Revenue
N/A
$1,003,782,000.00
Revenue This Year
$120.31
N/A
Revenue Next Year
$126.89
$17.97
P/E Ratio
N/A
$96.85
Revenue Growth
N/A
28.46
52 Week Low
$9.72
$16.10
52 Week High
$128.96
$30.48

Technical Indicators

Market Signals
Indicator
AAOI
APLS
Relative Strength Index (RSI) 65.22 26.61
Support Level $24.13 $16.89
Resistance Level N/A $20.42
Average True Range (ATR) 10.17 0.93
MACD 3.86 -0.21
Stochastic Oscillator 71.73 0.46

Price Performance

Historical Comparison
AAOI
APLS

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: